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ABSTRACT

Molecular mechanics and dynamics calculations were used to simulate reactions
of oxaliplatin and Pt(Me2dach)(oxalate) with methionine and guanine, where Me2dach is
N,N-dimethyl-1,2-diaminocyclohexane. The results were consistent with steric effects
that resulted in chelation when Pt(Me2dach)(oxalate) reacted with N-acetylmethionine
experimentally (Williams et al., 2013). The energy difference due to ligand bulk that was
predicted using molecular mechanics was also consistent with experimental results:
oxaliplatin’s ligand bulk did not prevent the formation of bis products with 9ethylguanine and N-acetylmethionine, but the ligand bulk of Pt(Me2dach)(oxalate) did
prevent bis product formation with N-acetylmethionine, resulting in chelation with the
sulfur and oxygen atoms of the methionine residue (Williams et al., 2013).
Pt(Me2dach)(oxalate) did not prevent bis products with 9-ethylguanine (Williams et al.,
2013).

Keywords: Molecular Mechanics, Oxaliplatin, Pt(Me2dach)(oxalate), Methionine,
Guanine
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CHAPTER 1

INTRODUCTION

Molecular mechanics is a form of software that models organic and inorganic
compounds through parameters that determine the conformation and energy of a
compound. Molecular mechanics software utilizes force fields, which are sets of
parameters used to calculate energy. An AMBER (Assisted Model Building with Energy
Refinement) force field was used in the molecular mechanics software because of its
parameters for amino acids and DNA bases, molecules which were of focus.1 The
AMBER force field has been modified several times from the force field developed by
Weiner and his colleagues in the 1980’s.2 How parameters are obtained varies from each
modification, but in general, these force fields rely heavily upon ab initio calculations of
simple molecules, X-rays of crystal structures, IR (Infrared spectroscopy), and NMR
(Nuclear Magnetic Resonance spectroscopy) spectra to obtain the data necessary to create
parameters for factors such as bond lengths, bond angles, and electrostatic interactions.2-4
This software was used to model oxaliplatin, a platinum-containing anticancer
compound used in the treatment of colorectal cancer (Figure 1.1).5-7 It was developed
and utilized because it is not cross-resistant with its predecessors, cisplatin and
carboplatin.8 Oxaliplatin and other platinum-containing anticancer compounds function
by having their leaving groups (the portion of the compound that is removed by another
molecule, for example, oxalate for oxaliplatin) replaced with two water molecules inside
1

a cell. Upon reaching the nucleus, the water molecules are replaced by DNA bases as
platinum binds to DNA. It is the binding to DNA that can result in replication errors that
lead to apoptosis. Though platinum is thermodynamically favored to bind to DNA bases
over amino acids, platinum is kinetically favored to bind to amino acids.9,10 It is
therefore relevant in anticancer research to determine what extent of bulk will shift
platinum’s kinetic preference to DNA bases.

Figure 1.1: Oxaliplatin
The carrier ligand is the top portion of
this molecule, including Pt. The leaving
ligand is everything below in this twodimensional representation.

In addition to oxaliplatin, molecular mechanics was also used to model
Pt(Me2dach)(oxalate), a derivative of oxaliplatin (Figure 1.2). The difference between
these two compounds is due to their carrier ligands (Figure 1.1). Oxaliplatin contains the
dach (diaminocyclohexane) carrier ligand, while Pt(Me2dach)(ox) contains the Me2dach
(1,2-dimethyl diaminocyclohexane) carrier ligand. Both compounds contain the oxalate
leaving group. Me2dach differs from dach in that both of its chiral nitrogen atoms have a
single bond with a methyl group, creating a larger bulk than dach. Since amino acids are
larger than DNA bases, our goal was to see if the bulk difference between oxaliplatin and
Pt(Me2dach)(ox) created a difference in reactivity between these two compounds with
guanine and methionine.
2

Figure 1.2: Pt(Me2dach)(oxalate)
Contains the oxalate leaving ligand like oxaliplatin,
but the carrier ligand contains two methyl groups that
replace two of the hydrogens in oxaliplatin’s dach
carrier ligand.
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CHAPTER 2

EXPERIMENT

Molecular mechanics data were obtained using HyperChem 7 (Hypercube, Inc.)
on a Dell Optiplex GX260 computer with Windows XP. An AMBER89 force field was
used with modifications to contain parameters developed in past research for platinum
atoms bound to guanine and methionine.3,11 To analyze the bulk difference between
Pt(Me2dach)(oxalate) and oxaliplatin, molecular mechanics was used to construct models
with varying conformations, including various chiralities of the amine nitrogens, carbons
1 and 2 of the cyclohexane chair of the carrier ligand, and the sulfur of the methionine
residue. Once structures were made, energy minimizations were done on the models.
Molecular dynamics calculations were then done on the models analogously with
previous research: models were simulated at 300 Kelvin for 250 picoseconds, with a
conformation saved at each picosecond and the lowest total energy of each conformation
was recorded.9
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CHAPTER 3

RESULTS

Oxaliplatin with bis-methionine: [Pt(dach)(N-AcMet-S)2]
To distinguish rotamers, the first two chiralities are those of the carbons of the
cyclohexane ring bound to the amine nitrogens. The next two chiralities are those of the
two sulfur atoms of the two methionine residues. Head-to-head (HH), tails-to-tails (TT),
head-to-tails (HT), or tails-to-head (TH) refer to the positioning of the methyl group
attached to each methionine’s sulfur atom. If it is bound in such a way that it points
above the platinum plane, it is in the heads (H) configuration, and below the platinum
plane is tails (T). The methyl groups’ orientations are listed in order from the methionine
residue on the left first.

Figure 3.1: RR-RR-HH, the lowest
total energy conformation for
oxaliplatin with bis-methionine, with
the methionine residues oriented
closest to viewer. The methyl groups
attached to the sulfur atom of each
methionine residue are pointing above
the platinum plane, while the rest of
each residue is positioned below the
platinum plane.
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In the graph below (table 3.1), it is shown that RR-RR-HH (Figure 3.1) was the
conformation that provided the lowest total energy. The reason why it was the lowest
total energy conformation can in part be explained by running single point calculations,
which show electrostatic interactions, hydrogen bond strain, and total bond strain.
Compared to the relatively highest total energy structures, the relatively lower total
energy structures had lower total bond strain and lower electrostatic interactions and
hydrogen bond strain.

Rotamer

Lowest Total Energy (kcal/mol)

Time (ps)

RR-RR-HH

-11.4834

85

RR-RR-TT

-6.49225

59

RR-RR-HT

-10.7318

91

RR-SS-HH

9.671332

2

RR-SS-TT

11.00478

158

RR-SS-HT

16.87738

1

RR-SR-HH

9.457934

10

RR-SR-TT

-10.4101

21

RR-SR-HT

19.58132

151

RR-SR-TH

-1.19333

32

Table 3.1

Oxaliplatin with bis-guanine: [Pt(dach)(9-EtG)2]
To distinguish rotamers, the first two chiralities listed are those of the two
cyclohexane ring carbons bound to the amine nitrogens. Since each guanine residue

6

contains no chiral atoms, the direction and placement of the hydrogen bonded to the C8
carbons (the carbons double-bonded to the N7 nitrogens bound to platinum) were used to
label conformations as HH (head-to-head), and lambda HT and delta HT.12 Lambda HT
refers to the C8 hydrogen bond pointing below and above the platinum plane from the
left and right guanine residues, respectively.12 Delta HT (Figure 3.2) refers to the C8
hydrogen pointing above and below the platinum plane from the left and right guanine
residues, respectively.12

Rotamer

Lowest Total Energy (kcal/mol)

Time (ps)

RR-HH

-16.7662

242

RR-Lambda HT

-16.097

142

RR-Delta HT

-16.998

164

Table 3.2

Figure 3.2: RR-Delta HT
From the left to right direction, the
carbon-hydrogen bond of the carbon
double-bonded to the nitrogen in each
guanine residue points above and
below the platinum plane.
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Pt(Me2dach) with bis-methionine: [Pt(Me2dach)(N-AcMet-S)2]
Rotamers were distinguished by the chiralities of the amine nitrogens and
cyclohexane ring carbons (ex. SRRS), and the chiralities of the sulfur atoms and the
orientation of the methyl groups bound to the sulfurs were distinguished by the same
method as the oxaliplatin with bis-methionine rotamers.
The energy differences seen in the structures below are mostly due to total bond
strain; SRRS-SR-HT (Figure 3.3, the lowest total energy structure) had a relatively low
total bond strain (~21 kcal/mole) compared to SRRS-SS-HT (Figure 3.4, the highest total
energy structure), which had a total bond strain of ~38 kcal/mol. The bond strain
difference is illustrated by how the square planar geometry of the four bonds to platinum
is distorted to a larger degree in SRRS-SS-HT (Figure 3.4).

Figures 3.3 & 3.4: SRRS-SRHT(above) and SRRS-SS-HT (below).
Note that in SRRS-SS-HT, the
platinum plane is to a larger degree
distorted from an ideal square planar
geometry due to bond strain.
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Rotamer

Lowest Total Energy (kcal/mol)

Time (ps)

SRRS-RR-HH

6.95555

242

SRRS-RR-TT

9.414564

249

SRRS-RR-HT

15.15593

115

SRRS-SR-HH

9.524042

159

SRRS-SR-TT

18.42109

49

SRRS-SR-HT

5.4734

73

SRRS-SR-TH

12.08102

21

SRRS-SS-HH

7.578558

177

SRRS-SS-TT

6.665445

218

SRRS-SS-HT

21.69378

68

Table 3.3

Pt(Me2dach) with bis-guanine: [Pt(Me2dach)(9-EtG)2]
Rotamers were distinguished like those of dach with bis-guanine, except the
amine nitrogens’ chiralities are included. The three conformations had similar
electrostatic interactions and hydrogen bond strains combined at about -23 kilocalories
per mole. SRRS-HH and SRRS-Delta HT had higher total bond strains because their
cyclohexane rings were out of the stable “chair” conformation.
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Rotamer

Lowest Total Energy (kcal/mol)

Time (ps)

SRRS-HH

-5.50239

102

SRRS-Lambda HT

-11.7471

249

SRRS- Delta HT

-6.87903

126

Table 3.4

SRRS S,O-Chelates: [(S,R,R,S)-Pt(Me2dach)(N-AcMet-S,O)]+
Chelates within the SRRS and RSSR chirality were separated by the chirality of
the sulfur atom and whether the carbonyl oxygen (OXT) pointed above or below the
platinum plane (up or down) and then whether it pointed toward or away from the
platinum atom (in or out). Electrostatic interactions, hydrogen bond strain, and total bond
strain differences were seen by comparing relatively low total energy structures to
relatively high total energy structures. In high energy structures, the total bond strain
makes the cyclohexane chair out of plane with the square planar geometry of the four
platinum bonds (Figure 3.5).

Figure 3.5: SRRS-R-COOH-up and
out
The bond strain is high enough that the
cyclohexane chair on the left side of
the molecule is nearly perpendicular to
the platinum plane though it should lie
within the plane.
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Lowest Total Energy
Rotamer

Time (ps)
(kcal/mol)

R-COOH up and in

22.19559

32 & 58

R-COOH up and out

33.47956

129

R-COOH down and in

21.1443

250

R-COOH down and out

13.86348

197

S-COOH up and in

14.2397

129

S-COOH up and out

31.66563

39

S-COOH down and in

19.78293

55

S-COOH down and out

16.3332

186 & 232

Table 3.5

RSSR S,O-Chelates: [(R,S,S,R)-Pt(Me2dach)(N-AcMet-S,O)]+
A similar relationship to the SRRS chelates was seen in that the low total energy
structures had both lower electrostatic interactions, hydrogen bond strain, and total bond
strain than the high total energy structures. The structures with the relatively lowest total
energies were the ones that had their cyclohexane chairs more in line with the platinum
plane.
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Lowest Total Energy
Rotamer

Time (ps)
(kcal/mol)

R-COOH up and in

19.23563

130

R-COOH up and out

36.70739

218

R-COOH down and in

17.73952

219

R-COOH down and out

21.28113

60

S-COOH up and in

19.00508

152

S-COOH up and out

33.68429

64

S-COOH down and in

21.64079

48

S-COOH down and out

28.57723

175

Table 3.6

In summary, all of the lowest total energy structures are listed:

Rotamer

Lowest Total Energy (kcal/mol)

Time (ps)

[Pt(dach)(N-AcMet-S)2]
RR-RR-HH

-11.4834

85

[Pt(dach)(9-EtG)2]
RR-Delta HT

-16.998

164

[Pt(Me2dach)(N-AcMet-S)2]
SRRS-SR-HT

5.4734

73

[Pt(Me2dach)(9-EtG)2]
SRRS-Lambda HT

-11.7471

249

[Pt(Me2dach)(N-AcMet-S,O)]+
R-COOH down and out

13.86348

197

[Pt(Me2dach)(N-AcMet-S,O)]+
R-COOH down and in

17.73952

219

Table 3.7
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CHAPTER 4

DISCUSSION

The lowest total energy conformation of oxaliplatin with bis-methionine was
about 6 kilocalories per mole higher than the lowest total energy conformation of
oxaliplatin with bis-guanine. With Pt(Me2dach) with bis-methionine, the lowest total
energy conformation was about 17 kilocalories per mole greater than the lowest total
energy conformation with bis-guanine. This 11 kilocalories per mole difference between
oxaliplatin and Pt(Me2dach)(ox) is the result of the bulk difference between dach and
Me2dach being used as carrier ligands. This is comparable to past research with the
Me4en ligand (N,N,N’,N’-tetramethylethylenediamine) in that bis products with
methionine “would have severe interligand clashes,” while this effect would be lessened
with bis-guanine products.11
NMR data revealed that the reaction of Pt(Me2dach)(ox) with N-acetylmethionine
resulted in chelation with the sulfur and oxygen atoms of a single methionine residue.1
Oxaliplatin could form bis products with methionine at high concentrations of Nacetylmethionine; at low concentrations a sulfur-nitrogen chelate could form.1 Both
Pt(Me2dach)(oxalate) and oxaliplatin could form bis products with 9-ethylguanine.1 This
is consistent with molecular mechanics and dynamics calculations in that the lowest total
energy structures of Pt(Me2dach)(oxalate) and oxaliplatin with bis products with guanine
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had comparably low total energy values. These values, as well as the energy of the
lowest total energy structure of oxaliplatin with bis-methionine, are significantly lower
than the energy of the lowest total energy conformation of Pt(Me2dach)(oxalate) with bismethionine (table 3.7), showing the thermodynamic disparity.
It was originally determined that the sulfur-oxygen chelates formed by the
reaction of Pt(Me2dach)(oxalate) with N-acetylmethionine were of SRRS (N,C,C,N)
chirality.1 It was later shown that when Pt(Me2dach)(oxalate) reacted with Nacetylmethionine, chelates were also made of RSSR chirality. Of the SRRS and RSSR
chelates, NMR and other spectra data were unable to determine any further the
conformations of the chelates, including the chiralities of the sulfur atoms. Molecular
mechanics and dynamics data showed three conformations of the SRRS chelates having
relatively low energies compared to the other conformations. The data predicts that the
SRRS chelates made have two conformations with the sulfur atoms in the S chirality and
one conformation with the sulfur atom in the R chirality. Of the RSSR chelates, both
spectra data and molecular mechanics data were insufficient to determine the
conformation of the RSSR chelates formed. Molecular mechanics and dynamics data
were unable to provide a prediction of the conformation because there were multiple
conformations of relatively low energy.
In regard to practical applications, the formation of sulfur-oxygen chelates by the
reaction of Pt(Me2dach)(ox) and N-acetylmethionine does not shift reactivity with
platinum in guanine’s favor because the chelate product is stable enough that it cannot be
knocked off by even a more thermodynamically favored reactant.1 Therefore, the ability
of Pt(Me2dach)(ox) to bind to DNA is limited by the formation of a product with an
14

amino acid that could possibly be stable for years. It is also significant that
Pt(Me2dach)(ox) and oxaliplatin reacted with N-acetylmethionine at equal rates, showing
that the extra bulk of the Me2dach ligand did not prevent the bonding of Nacetylmethionine before chelation.1 Therefore, it can be concluded that the bulk
difference between oxaliplatin and Pt(Me2dach)(ox) does not create a difference in
reactivity between methionine and guanine, thus not giving an advantage to either of
these compounds in this aspect of anticancer activity.
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